From: Do younger women with non-metastatic and non-inflammatory breast carcinoma have poor prognosis?
| Age (years) | Hazard ratio* | 95% confidence interval |
|---|---|---|
| Adjusted for both T and N stage | ||
| <40 | 1.00 | Referent |
| 40–49 | 0.76 | 0.62–0.93* |
| 50–59 | 1.00 | 0.83–1.27 |
| >=60 | 0.95 | 0.74–1.21 |
| Adjusted for T alone | ||
| <40 | 1.00 | Referent |
| 40–49 | 0.70 | 0.56–0.89* |
| 50–59 | 0.71 | 0.56–0.90* |
| >=60 | 0.89 | 0.70–1.1 |
| Adjusted for N stage alone | ||
| <40 | 1.00 | Referent |
| 40–49 | 0.75 | 0.60–0.94* |
| 50–59 | 0.76 | 0.60–0.96* |
| >=60 | 0.97 | 0.76–1.2 |